RA0332

antibody from Oursmab

Targeting: IL13 ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0332

Provider

Oursmab

Product name

Cendakimab (Biosimilar Reference Antibody) (IL13)

Antibody type

Monoclonal

Description

Cendakimab is an investigational human monoclonal antibody in clinical development for the treatment of moderate-to-severe atopic dermatitis. It functions as a targeted biologic therapy designed to block a specific cytokine pathway that is central to the type 2 inflammation driving the disease's hallmark symptoms: chronic itch, skin barrier dysfunction, and eczematous lesions. Clinical trials are ongoing to evaluate its efficacy in improving skin clearance and reducing pruritus compared to existing therapies.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.